These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37982173)

  • 1. Cancer-associated fibroblast-associated gene IGFBP2 promotes glioma progression through induction of M2 macrophage polarization.
    Zhang X; Sun X; Guo C; Li J; Liang G
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C252-C268. PubMed ID: 37982173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status.
    Zhou F; Shi Q; Fan X; Yu R; Wu Z; Wang B; Tian W; Yu T; Pan M; You Y; Wang Y
    Front Immunol; 2022; 13():841404. PubMed ID: 35265085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of HOXC10 gene on biological behaviors of glioma cells and mechanism in tumor microenvironment].
    Jiang WY; Lei QY; Liu SS; Yang L; Yang B; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):228-237. PubMed ID: 35316872
    [No Abstract]   [Full Text] [Related]  

  • 4. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ferroptosis-related risk genes on macrophage M1/M2 polarization and prognosis in glioblastoma.
    Xu X; Zhang Y; Liao C; Zhou H; Wu Y; Zhang W
    Front Cell Neurosci; 2023; 17():1294029. PubMed ID: 38283752
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
    Front Immunol; 2022; 13():974346. PubMed ID: 36275718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP2 expression predicts IDH-mutant glioma patient survival.
    Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
    Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
    Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J
    Front Immunol; 2023; 14():1338244. PubMed ID: 38250074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
    Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinster homolog 2 reduces malignancies of glioblastoma via PTEN/PI3K/AKT pathway.
    Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
    IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis.
    Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C
    J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Transcriptomic Signatures of Pancreatic Ductal Adenocarcinoma-Derived Exosomes That Promote Macrophage M2 Polarization and Predict Prognosis: S100A9 Reveals Tumor Progression.
    Tan S; Tang H; Zhang Z; Wang Y; Li H; Shi W; Ye H; Xie P; Zhou J
    Clin Med Insights Oncol; 2024; 18():11795549241239042. PubMed ID: 38510315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.
    Liu L; Yang Y; Duan H; He J; Sun L; Hu W; Zeng J
    Front Oncol; 2021; 11():611038. PubMed ID: 33937022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLEC7A regulates M2 macrophages to suppress the immune microenvironment and implies poorer prognosis of glioma.
    Wang J; Li X; Wang K; Li K; Gao Y; Xu J; Peng R; Zhang X; Zhang S; Zhou Y; Xu S; Zhang J
    Front Immunol; 2024; 15():1361351. PubMed ID: 38846954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic cancer-associated fibroblast markers in luminal breast cancer using weighted gene co-expression network analysis.
    Xu A; Xu XN; Luo Z; Huang X; Gong RQ; Fu DY
    Front Oncol; 2023; 13():1191660. PubMed ID: 37207166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.